Eli Lilly Canada is seeking a CMCPM for Radiopharmaceuticals to lead the creation and implementation of integrated Chemistry, Manufacturing, and Controls plans for assets from portfolio entry through global submissions and launch. In this role, you will provide strategic and operational leadership to CMC and global product teams, partnering with business units to translate scientific and clinical strategy into development and delivery goals.

What You'll Do

Partner with global program teams and therapeutic business units to translate preclinical, clinical, and asset strategy into CMC development & delivery goals.
Lead the creation, development, communication and implementation of integrated CMC plans for assets from portfolio entry through early-phase clinical development, inclusive of both therapeutics and imaging agents.
Leverage portfolio knowledge, development and financial acumen to enable investment strategies and optimization at both project and portfolio level.
Drive cross-functional CMC teams to maximize the value of data, create competitive plans, anticipate risks, communicate effectively, enable high quality decisions, and implement decisions.
Understand when and how to appropriately raise issues to teams and stakeholders, keeping both apprised of project status at the right level of detail.
Develop high performing matrix teams with an ability to quickly identify gaps in team effectiveness and implement remediation efforts.
Support Due Diligence efforts by leading CMC development plans while integrating and communicating key findings with stakeholders.
Participate in or lead continuous improvement projects which significantly impact the work and/or effectiveness of CMC development.

What We're Looking For

10+ years of drug development or radiopharmaceutical product experience.
Four-year degree, preferably in a scientific or engineering field.
Practical experience leading cross-functional projects, preferably within radiopharmaceutical CMC.
Demonstrated expertise in PM tools and processes (e.g., management of scope, timeline, cost, communications, risk and procurement as defined by PMBOK), with ability to identify and drive business process improvements and incorporate new PM technologies/methodologies.
Demonstrated ability to communicate complex issues accurately and succinctly, both horizontally and vertically across the development organization.

Nice to Have

Advanced degree (Master of Science, Master of Business Administration, Ph.D. or PharmD.).
Understanding of development phases, associated radiopharmaceutical CMC deliverables, and interactions of various functional areas and how each relates to a comprehensive development strategy.
Experience in clinically-enabling radiopharmaceutical CMC development, inclusive of therapeutics and imaging.
Understanding of early- & late-phase therapeutic landscapes, including clinical & regulatory environments.

Team & Environment

You will partner with technical leaders and department heads, co-leading the cross-functional team.

Benefits & Compensation

Annual salary range: $151,500 - $222,200.
Eligibility for a company bonus (depending, in part, on company and individual performance).
Comprehensive benefit program including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).

Work Mode

This role operates on a hybrid work schedule.

Eli Lilly Canada is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.